Unexpected Hepatoprotective Effects of the Neuroproteсtor Lithium Ascorbate in a Model of a ʺWesternʺ Diet with Iron Overload and Multiple Organ Pathology
This study demonstrates that the neuroprotective agent lithium ascorbate exhibits significant hepatoprotective effects in a rat model of Western diet-induced NAFLD with iron overload, outperforming myoinositol by normalizing specific hematological parameters and reducing hepatic iron accumulation, thereby suggesting its potential utility in treating hepatic encephalopathy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The liver is the body's tireless chemical processing plant, filtering blood, storing energy, and neutralizing toxins. When this organ is overwhelmed by a diet rich in saturated fats and simple sugars, it can become clogged with fat, a condition known as fatty liver disease. This issue is often made worse by an excess of iron, a mineral that, while essential, becomes destructive when it accumulates in tissues. Too much iron acts like a rusting agent inside the body, generating harmful free radicals that damage cells and trigger inflammation. This combination of fatty liver and iron overload creates a dangerous cycle that can spread damage to the kidneys, heart, and brain, leading to a complex state of multi-organ failure. For decades, scientists have searched for ways to break this cycle, looking for substances that could protect the liver without causing harm elsewhere.
In a recent study, researchers investigated an unexpected candidate for this job: a compound called lithium ascorbate. While lithium is widely known as a mood-stabilizing medication for the brain, and ascorbate is simply vitamin C, the researchers were not testing this combination for mental health. Instead, they wanted to see if this specific salt could shield the liver from the ravages of a "Western" diet loaded with palm oil, fructose, and iron. To find out, they created a precise model of the disease in rats. They fed some animals a diet high in fat and sugar while injecting them with iron, effectively forcing their livers to become fatty and rusty at the same time. Once the disease was established, they treated one group with lithium ascorbate and another with myoinositol, a substance already known to protect the liver, to see which one could reverse the damage.
The results revealed a surprising twist in how these substances work. Both treatments helped lower the levels of iron in the blood and reduced the stress on the liver, bringing key markers like liver enzymes and kidney function back toward normal. However, the lithium ascorbate group showed a unique and powerful advantage. While the myoinositol group saw improvements, their livers still contained significant amounts of iron trapped inside specific immune cells called Kupffer cells. In contrast, the rats treated with lithium ascorbate showed a dramatic reduction in these iron-filled cells. It was as if the lithium compound did not just lower the overall iron in the blood, but actively helped the liver's own cleanup crew to clear out the toxic deposits that had built up over time.
Beyond the liver, the lithium treatment seemed to calm the entire body's reaction to the disease. The animals treated with lithium ascorbate had lower levels of inflammation and fewer blood platelets, which are involved in clotting, suggesting a reduction in the risk of blood clots. They also showed a normalization of vitamin B12 levels, which had dropped dangerously low in the sick animals, and a return of healthy red blood cell production. The researchers observed that the rats on the lithium treatment became more active and less aggressive, with their fur returning to a clean, smooth condition, whereas the untreated animals remained lethargic and rough-coated. Histological examinations confirmed these findings, showing that the livers of the treated animals were free of the heavy iron deposits that plagued the others, and their heart and brain tissues remained clear of damage.
The study suggests that lithium ascorbate offers a broader range of protection than previously thought, acting not just on the brain but as a potent shield for the liver and other organs. While the researchers noted that the compound is non-toxic and safe in the doses used, they emphasized that these findings come from animal models. The ability of this neuroprotective substance to reduce iron overload in the liver opens a new avenue for thinking about how to treat complex metabolic diseases where iron toxicity and fatty liver go hand in hand. It appears that by targeting the specific mechanisms of iron storage and inflammation, this compound might offer a way to halt the progression of multi-organ damage, providing a glimmer of hope for future therapies that address the root causes of these interconnected health crises.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.